The coagulation cascade: initiation, maintenance, and regulation.

[1]  K. Kurachi,et al.  Activation of human factor IX (Christmas factor). , 1978, The Journal of clinical investigation.

[2]  J. Nishioka,et al.  Protein C inhibitor. Purification from human plasma and characterization. , 1983, The Journal of biological chemistry.

[3]  Y. Nemerson,et al.  Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor. , 1985, Thrombosis research.

[4]  E. Davie,et al.  Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.

[5]  W. Kisiel.  Human Plasma Protein C: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION BY α-THROMBIN , 1979 .

[6]  C. Esmon,et al.  Formation of a calcium-binding site on bovine activated factor V following recombination of the isolated subunits. , 1982, The Journal of biological chemistry.

[7]  K. Mann,et al.  Thrombin-catalyzed activation of single chain bovine factor V. , 1979, The Journal of biological chemistry.

[8]  L. Lorand,et al.  Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII. , 1991, Biochemistry.

[9]  E. Davie,et al.  Preparation and properties of bovine factor VIII (antihemophilic factor). , 1980, Biochemistry.

[10]  R. Doolittle,et al.  Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. , 1974, Biochemistry.

[11]  K. Fujikawa,et al.  The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Davie,et al.  Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. Kane,et al.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. , 1988, Blood.

[14]  L. Lorand.  Activation of Blood Coagulation Factor XIII a , 1986, Annals of the New York Academy of Sciences.

[15]  S. Rapaport,et al.  Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. , 1989, Blood.

[16]  H. ten Cate,et al.  Factor IX is activated in vivo by the tissue factor mechanism. , 1990, Blood.

[17]  P. Reitsma,et al.  Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). , 1989, Blood.

[18]  Y. Nemerson,et al.  Association of tissue factor activity with the surface of cultured cells. , 1975, The Journal of clinical investigation.

[19]  J. Griffin,et al.  Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.

[20]  A. Laudano,et al.  Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. , 1980, Biochemistry.

[21]  E. Davie,et al.  Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. , 1977, Biochemistry.

[22]  A. Guha,et al.  Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Esmon.  The regulation of natural anticoagulant pathways , 1987, Science.

[24]  A. Cantor,et al.  Recognition site directing vitamin K-dependent γ-carboxylation resides on the propeptide of factor IX , 1987, Cell.

[25]  P. Fernlund,et al.  Vitamin K dependent modifications of glutamic acid residues in prothrombin. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Fujikawa,et al.  Inhibition of bovine factor IXa and factor Xabeta by antithrombin III. , 1976, Biochemistry.

[27]  J. Stenflo,et al.  Vitamin K-dependent formation of gamma-carboxyglutamic acid. , 1977, Annual review of biochemistry.

[28]  K Fujikawa,et al.  Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. , 1991, The Journal of biological chemistry.

[29]  D. Tollefsen,et al.  Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. , 1982, The Journal of biological chemistry.

[30]  C. Esmon,et al.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. , 1982, The Journal of biological chemistry.

[31]  L. Thim,et al.  Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. , 1988, Biochemistry.

[32]  M. Crossley,et al.  Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B , 1990, Nature.

[33]  Y. Nemerson,et al.  Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. , 1976, The Journal of biological chemistry.

[34]  G. Broze.  Binding of human factor VII and VIIa to monocytes. , 1982, The Journal of clinical investigation.

[35]  J. Finlayson,et al.  The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases , 1977 .

[36]  R. Rosenberg,et al.  The purification and mechanism of action of human antithrombin-heparin cofactor. , 1973, The Journal of biological chemistry.

[37]  L. Deaven,et al.  Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. , 1987, Biochemistry.

[38]  J. Miletich,et al.  Purification of human brain tissue factor. , 1985, The Journal of biological chemistry.

[39]  J. Griffin,et al.  Physiologic inhibition of human activated protein C by alpha 1-antitrypsin. , 1988, The Journal of biological chemistry.

[40]  P. Majerus,et al.  Isolation and characterization of thrombomodulin from human placenta. , 1984, The Journal of biological chemistry.

[41]  C. Esmon,et al.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. , 1982, The Journal of biological chemistry.

[42]  W. Konigsberg,et al.  Purification and characterization of bovine tissue factor. , 1981, The Journal of biological chemistry.

[43]  S. Yamamoto,et al.  Gene structure of human thrombomodulin, a cofactor for thrombin-catalyzed activation of protein C. , 1988, Journal of biochemistry.

[44]  W. Kisiel,et al.  Interaction of vitamin K dependent proteins with membranes. , 1978, Biochemistry.

[45]  C. Esmon,et al.  Recurrent venous thromboembolism in patients with a partial deficiency of protein S. , 1984, The New England journal of medicine.

[46]  Y. Nemerson,et al.  Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor. , 1980, The Journal of biological chemistry.

[47]  Y Komiyama,et al.  Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. , 1990, Biochemistry.

[48]  D D Monkovic,et al.  Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.

[49]  Y. Nemerson,et al.  Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. , 1986, Biochemistry.

[50]  L. Sottrup-jensen.  4 – α2-Macroglobulin and Related Thiol Ester Plasma Proteins , 1987 .

[51]  Y. Nemerson,et al.  Binding of the protein component of tissue factor to phospholipids. , 1970, Biochemistry.

[52]  W. Kisiel,et al.  Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. , 1989, The Journal of biological chemistry.

[53]  W. Novotny,et al.  Regulation of coagulation by a multivalent Kunitz-type inhibitor. , 1990, Biochemistry.

[54]  J. Shafer,et al.  Role of calcium ion in the generation of factor XIII activity. , 1991, Biochemistry.

[55]  C. Esmon.  The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. , 1979, The Journal of biological chemistry.

[56]  Y. Nemerson,et al.  Evidence for the presence of tissue factor activity on subendothelium. , 1989, Blood.

[57]  B. Keyt,et al.  Structure of human factor VIII , 1984, Nature.

[58]  D. Cines,et al.  Identification of the fibrinogen receptor on human platelets by photoaffinity labeling. , 1982, The Journal of biological chemistry.

[59]  D. Beeler,et al.  Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[60]  L. Patthy.  Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules , 1985, Cell.

[61]  K. Kurachi,et al.  Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor). , 1977, Biochemistry.

[62]  P. Hass,et al.  Characterization of recombinant human factor VIII. , 1987, The Journal of biological chemistry.

[63]  G. Vehar,et al.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. , 1986, Biochemistry.

[64]  Susan G. Brown,et al.  Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor , 1989, Nature.

[65]  R. Marlar,et al.  Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme , 1982 .

[66]  N. Mackman,et al.  Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. , 1989, Biochemistry.

[67]  Kenneth G. Mann,et al.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes , 1990 .

[68]  R. Lerner,et al.  Stimulation of Human Leukocyte Thromboplastic Activity by Endotoxin 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[69]  S. Williams,et al.  Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells. , 1989 .

[71]  R. Bertina,et al.  The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. , 1990, The Biochemical journal.

[72]  H. Hemker,et al.  The role of phospholipid and factor VIIIa in the activation of bovine factor X. , 1981, The Journal of biological chemistry.

[73]  L. Lorand,et al.  Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. , 1974, Biochemistry.

[74]  K. Kurachi,et al.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). , 1985, Biochemistry.

[75]  L. Lorand,et al.  ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN. , 1964, Archives of biochemistry and biophysics.

[76]  K. Fujikawa,et al.  Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). , 1977, Biochemistry.

[77]  A. Guha,et al.  Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[78]  G. Knutson,et al.  Molecular cloning of a cDNA encoding human antihaemophilic factor , 1984, Nature.

[79]  K. Mann,et al.  Coordinate binding of factor Va and factor Xa to the unstimulated platelet. , 1981, The Journal of biological chemistry.

[80]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[81]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[82]  C. Esmon,et al.  Thrombomodulin blocks the ability of thrombin to activate platelets. , 1983, The Journal of biological chemistry.

[83]  L. Petersen,et al.  Autoactivation of human recombinant coagulation factor VII. , 1989, Biochemistry.

[84]  C. Esmon,et al.  Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, The Journal of biological chemistry.

[85]  Z. Ruggeri,et al.  von Willebrand factor and von Willebrand disease. , 1987, Blood.

[86]  W. Kisiel,et al.  Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. , 1990, Biochemical and Biophysical Research Communications - BBRC.

[87]  M. Stemerman,et al.  Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts , 1977 .

[88]  Kathleen M. Smith,et al.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Sixma,et al.  Structure-function relationship of human von Willebrand factor. , 1987, Blood.

[90]  N. Mackman,et al.  Functional analysis of the human tissue factor promoter and induction by serum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Howard,et al.  The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. , 1974, The Journal of biological chemistry.

[92]  E. Davie,et al.  Factor XI deficiency in Ashkenazi Jews in Israel. , 1991, The New England journal of medicine.

[93]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[94]  B. Dahlbäck,et al.  Thrombin-catalyzed activation of human coagulation factor V. , 1982, The Journal of biological chemistry.

[95]  K. Berkner,et al.  Propeptide of human protein C is necessary for gamma-carboxylation. , 1987, Biochemistry.

[96]  S. Magnusson,et al.  Primary structure of the vitamin K‐dependent part of prothrombin , 1974, FEBS letters.

[97]  S. Rapaport,et al.  Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[98]  W. Kisiel,et al.  Anticoagulant properties of bovine plasma protein C following activation by thrombin. , 1977, Biochemistry.

[99]  K. Norris,et al.  Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. , 1990, The Journal of biological chemistry.

[100]  E. Davie,et al.  Structural features of the proteins participating in blood coagulation and fibrinolysis. , 1986, Cold Spring Harbor symposia on quantitative biology.

[101]  K. Fujikawa,et al.  Amino acid sequence of the a subunit of human factor XIII. , 1986, Biochemistry.

[102]  F. Walker.  Regulation of activated protein C by a new protein. A possible function for bovine protein S. , 1980, The Journal of biological chemistry.

[103]  E. Davie,et al.  Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. , 1990, The Journal of biological chemistry.

[104]  K. Kurachi,et al.  Characterization of a cDNA coding for human factor VII. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Blombäck,et al.  THE MOLECULAR STRUCTURE OF FIBRINOGEN , 1972, Annals of the New York Academy of Sciences.

[106]  Y. Nemerson,et al.  An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage. , 1986, Biochemistry.

[107]  A. Bui,et al.  cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[108]  S. Pizzo,et al.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. , 1973, The Journal of biological chemistry.